Key Inflection Points

Proof of the mechanism in the clinic (the molecule works as expected)

Proof of concept (positive clinical effect)

Significant adoption from the clinical community (increasing rate of adoption)

Proof of technology (can scale rapidly)

Consumer product adoption (rapid market penetration or creates a significant new market)

Sometimes our timelines might require the licensing of an existing technology that is:

  • Ready as an investigational new drug or medical device
  • May be ready for an early to mid-stage clinical trial
  • May be an experimental drug candidate or asset that was shelved by a pharmaceutical company for strategic reasons
©2017
Cerus Advisors
DMCC